Malaysia Public Health Expert Calls for Stringent Laws on Flavored E-Cigarettes to Protect Youth

Regulations by 2FIRSTS.ai
Jun.27.2024
Malaysia Public Health Expert Calls for Stringent Laws on Flavored E-Cigarettes to Protect Youth
Malaysia public health expert Prof Dr Sharifa Ezat Wan Puteh urged to ban e-cigarettes, especially those with caffeine.

According to The Sun's report on June 27th, Professor Dr. Sharifa Ezat Wan Puteh, an expert in public health medicine at the National University of Malaysia, recently stated that laws should be enacted to prohibit e-cigarettes, especially those containing caffeine.

 

She suggested legislation to restrict the types and flavors of e-cigarettes, similar to Denmark, Estonia, and Slovenia where only tobacco and mint flavored e-cigarettes can be sold. Alternatively, like Australia, e-cigarettes could only be sold with a prescription and flavors limited to tobacco, mint, and menthol.

 

Izat further stated that currently over 30 countries worldwide have banned the sale of e-cigarettes as consumer products, meaning flavored e-cigarettes are not allowed to be sold.

 

She pointed out that flavored e-cigarettes may attract young people to become interested in them, as the smoking experience is enjoyable and customizable, which could increase the likelihood of them developing a smoking habit.

 

Izat stated that laws should also mandate the disclosure of nicotine concentration and ingredients, and impose strict quality control on e-cigarettes to prevent the addition of highly harmful additives and mixtures, such as delta-9-tetrahydrocannabinol, cannabinol, or synthetic drugs.

 

She also called for strict regulation and publicity of the use of e-cigarettes to deliver compounds such as vitamins.

 

The United States FDA classifies caffeine as a drug and food additive, widely used in various beverages, with a recommended maximum daily intake of 400mg. However, an increasing number of male and female students in Malaysia are becoming dependent on caffeine-containing e-cigarettes, especially coffee-flavored ones, putting them at high risk for health issues.

 

Caffeine is the most commonly used drug in the world, being utilized both as a prescription and over-the-counter medication. It is known for its ability to boost alertness, combat fatigue, and enhance the effects of certain pain medications. When inhaled through smoking, it can produce similar effects to other stimulants, but due to the potential presence of harmful additives such as volatile organic compounds (VOCs), the risks are higher, which can lead to heart disease, palpitations, and insomnia.

 

Some sellers add vitamin E acetate to enhance the flavor, but volatile organic compounds are harmful and may be released from the flavored e-cigarette liquid, especially in coffee-flavored e-cigarette liquids.

 

In addition, Izzat stated that inhaling caffeine through e-cigarettes directly into the lungs may cause irritation, inflammation, and other respiratory issues.

 

High doses of caffeine are concerning because it is a strong stimulant that can increase heart rate and blood pressure. In theory, this could lead to serious cardiovascular issues, such as cardiac arrest. While such high doses may not be obtained from regular e-cigarette use, the risks of illness still need to be a cause for concern.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
KT&G’s Lil Strengthens Market Lead in Korea as Heated Tobacco Share Reaches 47.4%
KT&G’s Lil Strengthens Market Lead in Korea as Heated Tobacco Share Reaches 47.4%
According to South Korea’s UpKorea, KT&G’s heated tobacco brand Lil reached a 47.4% share of Korea’s heated tobacco stick market in the first quarter of 2026. The company is expanding its next-generation products (NGP) business through product development, technology investment and overseas growth. KT&G reported NGP sales of 890.1 billion won (approximately US$650 million) in 2025, up significantly from 279.3 billion won in 2020. Lil products are now available in 34 markets, while KT&G continues building its technology portfolio through patents and multiple product platforms.
Jul.23
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
The UK government has announced that HM Revenue & Customs (HMRC) will carry out more than 30,000 interventions targeting businesses and retail premises during the 2026-2027 financial year. The actions will focus on tax fraud, illegal goods sales and businesses involved in unlawful activities through retail channels. The government said illegal tobacco and illegal vape sales remain areas of concern. The move shows that UK enforcement against illegal nicotine products is expanding from import and supply channels toward retail-level oversight, alongside the upcoming introduction of the Vaping Products Duty.
Jul.24